miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.

Cai, Chao; Chen, Qing-Biao; Han, Zhao-Dong; Zhang, Yan-Qiong; He, Hui-Chan; Chen, Jia-Hong; Chen, Yan-Ru; Yang, Sheng-Bang; Wu, Yong-Ding; Zeng, Yan-Ru; Qin, Guo-Qiang; Liang, Yu-Xiang; Dai, Qi-Shan; Jiang, Fu-Neng; Wu, Shu-lin; Zeng, Guo-Hua; Zhong, Wei-De; Wu, Chin-Lee

Cai, Chao; Chen, Qing-Biao; Han, Zhao-Dong; Zhang, Yan-Qiong; He, Hui-Chan; Chen, Jia-Hong; Chen, Yan-Ru; Yang, Sheng-Bang; Wu, Yong-Ding; Zeng, Yan-Ru; Qin, Guo-Qiang; Liang, Yu-Xiang; Dai, Qi-Shan; Jiang, Fu-Neng; Wu, Shu-lin; Zeng, Guo-Hua; Zhong, Wei-De; Wu, Chin-Lee.

Afiliación

Cai C; Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, and Guangdong Key Laboratory of Urology, Guangzhou, China.
Chen QB; Guangdong Provincial Institute of Nephrology, Southern Medical University, Guangzhou, China.
Han ZD; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Zhang YQ; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
He HC; Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, and Guangdong Key Laboratory of Urology, Guangzhou, China. Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's
Chen JH; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Chen YR; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Yang SB; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Wu YD; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Zeng YR; Guangdong Provincial Institute of Nephrology, Southern Medical University, Guangzhou, China. Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Qin GQ; Central Hospital of Panyu District, Guangzhou, China.
Liang YX; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Dai QS; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Jiang FN; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Wu SL; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Zeng GH; Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, and Guangdong Key Laboratory of Urology, Guangzhou, China.
Zhong WD; Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, and Guangdong Key Laboratory of Urology, Guangzhou, China. Guangdong Provincial Institute of Nephrology, Southern Medical University, Guangzhou, China. Department of Urology, Guan
Wu CL; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Department of Urology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. zhongwd2009@live.cn cwu2@partners.org.

Clin Cancer Res ; 21(21): 4922-34, 2015 Nov 01.

Article en En | MEDLINE | ID: mdl-26080838

Asunto(s)

MicroARNs/genética; Neoplasias de la Próstata/genética; Neoplasias de la Próstata/patología; Interferencia de ARN; Proteínas Quinasas S6 Ribosómicas 70-kDa/genética; Regiones no Traducidas 3'; Animales; Apoptosis/genética; Secuencia de Bases; Sitios de Unión; Cadherinas/genética; Cadherinas/metabolismo; Línea Celular Tumoral; Movimiento Celular/genética; Modelos Animales de Enfermedad; Progresión de la Enfermedad; Regulación Neoplásica de la Expresión Génica; Humanos; Masculino; Metaloproteinasa 9 de la Matriz/genética; Metaloproteinasa 9 de la Matriz/metabolismo; Ratones; MicroARNs/química; Neovascularización Patológica/genética; Pronóstico; Neoplasias de la Próstata/metabolismo; Neoplasias de la Próstata/mortalidad; Proteómica/métodos; ARN Mensajero/química; ARN Mensajero/genética; Proteínas Quinasas S6 Ribosómicas 70-kDa/química; Carga Tumoral/genética; Factor A de Crecimiento Endotelial Vascular/genética; Factor A de Crecimiento Endotelial Vascular/metabolismo; Ensayos Antitumor por Modelo de Xenoinjerto; Proteína Letal Asociada a bcl/genética; Proteína Letal Asociada a bcl/metabolismo

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteínas Quinasas S6 Ribosómicas 70-kDa / MicroARNs / Interferencia de ARN Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google